We’re excited to be investing not just in our company’s future, but also the future of science in the UK. Our new $105m Center for Scientific Excellence in Hull is the largest single investment in the company’s history. Once complete, it will be one of RB’s biggest healthcare development centers complementing other major R&D facilities around the world.
“The Center for Scientific Excellence is a truly exciting project, which reconfirms the relevance of Hull to our global R&D operations.” Sharon James, SVP R&D
For us, a great collaborative environment, the right support systems and a workplace that our people can thrive in, is key to success. Our new center will fuse together world class science and technology so we stay ahead of the game and remain leaders in our field.
The highly sustainable building will house a Good Manufacturing Practice (GMP) health development facility to support the creation and testing of cutting-edge consumer health innovations.
Hull City Council’s Planning Committee on Wednesday 4th November 2015 granted approval for our new R&D facility. This means the development based at our RB Dansom Lane site, can now go forward as planned, ensuring Hull remains one of our most important facilities across our global R&D operations.
Our investment goes beyond our building and our people. We want to bring the entire Hull community on the journey, creating a community of scientific excellence. Through local educational initiatives we’re encouraging young people to realize just how exciting a Science, Technology, Engineering or Maths (STEM) led career can really be.
Just like RB, the city of Hull is a place that dares to be different and one where our company has a long-standing heritage. Rooted in culture and filled with surprises, it has something for everyone from the historic old town and the museum quarter, to the impressive Humber Bridge. With strong employment, great schools and a choice of universities in the region, Hull offers an abundance of opportunity for families of all sizes, young and old.